...
首页> 外文期刊>Journal of pediatric and adolescent gynecology >Treatment Modalities in Adolescents Who Present with Heavy Menstrual Bleeding
【24h】

Treatment Modalities in Adolescents Who Present with Heavy Menstrual Bleeding

机译:患有大量月经出血的青少年的治疗方式

获取原文
获取原文并翻译 | 示例
           

摘要

Study ObjectiveOn this study we sought to determine the relationship of bleeding disorders to iron deficiency anemia. Additionally, this study was undertaken to examine all current treatment modalities used in a menorrhagia clinic with respect to heavy menstrual bleeding management to identify the most effective options for menstrual management in the setting of an underlying bleeding disorder. Design, Setting, Participants, Interventions, and Main Outcome MeasuresWe performed a retrospective chart review of adolescents younger than 21?years with heavy menstrual bleeding attending a multidisciplinary hematology-adolescent gynecology clinic. Information including demographic characteristics, bleeding diathesis, hematologic parameters, treatment, and the diagnosis was extracted from each chart. Subjects were grouped into 2 categories on the basis of the diagnosis of a bleeding disorder. Hemoglobin level, iron deficiency anemia, and need for transfusion were compared between a bleeding disorder and no bleeding disorder group. Subjects were grouped into categories depending on hormonal modality and treatment success of the groups were compared. ResultsSeventy-three subjects were tested for a bleeding disorder. Of the subjects who completed testing, 34 (46%) were diagnosed with a bleeding disorder. Thirty-nine subjects (54%) had heavy menstrual bleeding because of other causes. There was no significant difference in hemoglobin between those with and without a bleeding disorder. Iron deficiency anemia was significantly higher in subjects without a bleeding disorder. In a comparison of hormone therapy success, the levonorgestrel intrauterine device (89%, 8 out of 9 subjects) had the highest rate of menstrual suppression followed by norethindrone acetate 5-10?mg/d (83%, 5 out of 6 subjects), and the transdermal patch (80%, 4 out of 5 subjects). All subjects using tranexamic acid as well as hormonal therapy had 100% achievement of menstrual suppression. ConclusionA high frequency of bleeding disorders was found in those tested. Subjects with a bleeding disorder were less likely to present with severe anemia requiring blood transfusion and less likely to have iron deficiency anemia. Although combined oral contraceptives were commonly used clinically for menstrual suppression, they were not found to be the most effective option.
机译:研究目标师这项研究我们试图确定出血障碍对缺铁性贫血的关系。此外,本研究旨在检查大量月经出血管理中美甲诊所中使用的所有目前治疗方式,以确定在潜在的出血障碍的环境中的月经管理中最有效的选择。设计,设定,参与者,干预和主要结果衡量我们对年龄小于21岁以下的青少年进行了回顾性图表审查,其次过大学血液学 - 青少年妇科诊所的重重月经出血。在每个图表中提取包括人口统计学特征,出血性,血液学参数,治疗和诊断的信息。受试者在诊断出血障碍的基础上分为2个类别。比较血红蛋白水平,缺铁性贫血和输血需求在出血性疾病和没有出血障碍组之间进行比较。根据激素的方式分组,将受试者分组,并比较了群体的治疗成功。测试了三个受试者进行了出血障碍。完成测试的受试者,34(46%)被诊断出具有出血障碍。由于其他原因,三十九次受试者(54%)重沉重的月经出血。血红蛋白与没有出血障碍的人之间没有显着差异。没有出血性疾病的受试者的铁缺乏贫血显着高。在激素治疗成功的比较中,左旋林宫内节育器(89%,8个受试者中的8个)的月经抑制率最高,然后是诺伊丁酮醋酸盐5-10?Mg / D(83%,5个受试者中的5个) ,透皮贴剂(80%,5个受试者中的40%)。所有受试者使用Tranexamic酸以及荷尔蒙治疗的10%的月经抑制成就。结论在测试的那些中发现了高频率的出血障碍。具有出血性疾病的受试者不太可能存在严重的贫血,需要输血,并且不太可能具有缺铁性贫血。虽然组合口服避孕药常用于临床上用于月经抑制,但它们未被发现是最有效的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号